SCHEMBL32686935

SCHEMBL32686935

O=C1c2ccccc2[C@@H](Cc2ccccc2C(F)(F)F)N1Cc1ccc2[nH]c(=O)oc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IL4I1 Q96RQ9 1/20 0.40
▸ HPGD P15428 2/20 0.37
▸ P2RX7 Q99572 2/20 0.36
▸ MAPT P10636 4/20 0.35
▸ MAPK1 P28482 4/20 0.35
▸ LMNA P02545 3/20 0.35
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ HCRTR1 O43613 1/20 0.35
▸ HCRTR2 O43614 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ GRIA1 P42261 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.33
▸ OGT O15294 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32686788 1.00 IL4I1 (0.40) IL4I1HPGDP2RX7MAPTMAPK1
SCHEMBL31667531 0.88 IL4I1 (0.42) IL4I1HPGDMAPTMAPK1LMNA
SCHEMBL31667602 0.86 IL4I1 (0.42) IL4I1HPGDMAPTMAPK1LMNA
SCHEMBL31666968 0.86 IL4I1 (0.44) IL4I1HPGDMAPTMAPK1LMNA
SCHEMBL31666982 0.86 HPGD (0.43) IL4I1HPGDMAPTMAPK1LMNA
SCHEMBL31667717 0.85 MEN1 (0.45) IL4I1HPGDMAPTMAPK1LMNA
SCHEMBL31667679 0.85 MEN1 (0.45) IL4I1HPGDMAPTMAPK1LMNA
SCHEMBL31666930 0.85 MEN1 (0.45) IL4I1HPGDMAPTMAPK1LMNA
SCHEMBL32686872 0.84 IL4I1 (0.41) IL4I1HPGDMAPTMAPK1LMNA
SCHEMBL31666995 0.84 PDE10A (0.42) IL4I1HPGDMAPTMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF SIRONAX LTD (KY) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078130-A1 NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF NAMPT, NNMT, SARM1 IL4I1 2872/4885HPGD 520/4885P2RX7 1057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback